Drugs online research references
Ciprofloxacin prevents the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat.
Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.
Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Uptake of fluoroquinolones in human monocytes isolated from peripheral blood.
Effects of quinolones on interleukin 1 production in vitro by human monocytes.
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Antimicrobial activity of intravenous quinolones on the intestinal microflora in dogs.
Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Therapeutic efficacy of intravenous and oral ciprofloxacin in experimental murine infections.
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
Expression of the recA gene is reduced in Escherichia coli topoisomerase I mutants.
Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.
Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996.
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative.
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus
Outer membrane proteins of Klebsiella pneumoniae after exposure to ciprofloxacin.
Bacterial flora in laryngeal carcinoma and in postoperative scars of patients treated prophylactically by ciprofloxacin
Assessment of antibiotic levels in lung tissue with erosion-controlled dosage forms.
Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.
Gyrase inhibitor in the local treatment of the chronically infected middle ear following surgery
In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
Mechanism of action of lomefloxacin.
Isolation and structure elucidation of an intermediate in the photodegradation of ciprofloxacin.
Antibacterial activity of lomefloxacin against Brucella melitensis.
Role of fluoroquinolones in lower respiratory tract infections.
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.
Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Ciprofloxacin treatment of malignant external otitis.
In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.
Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Molecular epidemiology of endemic ciprofloxacin-susceptible and -resistant Enterobacteriaceae.
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.
Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.
Effect of quinolones on mice experimental infection by Plasmodium berghei and their possible therapeutic usefulness
Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin.
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Adverse drug reaction monitoring of ciprofloxacin in pediatric practice.
Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureus.
The role of ciprofloxacine metabolites in its biliary and urinary elimination in man
Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition.
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide. A decision analysis.
Widespread occurrence of multiple drug-resistant Salmonella typhi in India.
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing.
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes.
Resistance of recent Neisseria gonorrhoeae isolates in Nigeria and outcome of single-dose treatment with ciprofloxacin.
In vitro activity of the newer quinolones compared with the classic ones and tobramycin.
Pharmacokinetics of three newer quinolones in pregnant and lactating women.
Therapy of pulmonary nocardiosis in immunocompromised mice.
Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
Treatment of infections in non-neutropenic patients with cancer, AIDS, or renal transplant using ciprofloxacin.
The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Placental transfer of enrofloxacin and ciprofloxacin in rabbits.
Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program.
In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains
A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution.
The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections
In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.
In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration
Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.
Clearance and distribution of ciprofloxacin after intravitreal injection.
Antibiotic-induced release of endotoxin from bacteria in vitro.
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.
Evaluation of the efficacy of different antibiotics in inhibiting colonisation of Vibrio cholerae O1 in the rabbit intestine.
Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics.
Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy.
Influence of ciprofloxacin on the ultrastructure of gram-negative and gram-positive bacteria.
Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes.
In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.
Transintestinal elimination of ciprofloxacin in humans--concomitant assessment of its metabolites in serum, ileum and colon.
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Influence of new quinolones on normal immune capabilities.
Transintestinal elimination of ciprofloxacin.
Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci.
In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin
Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Ciprofloxacine: evaluation of its biliary elimination in man
Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.
The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms
Ciprofloxacin for treatment of severe typhoid fever in children.
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.
Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
Economic implications of oral treatment replacing parenteral therapy in antimicrobial chemotherapy.
Treatment of chronic osteomyelitis with ciprofloxacin.
In vitro antibacterial activity and clinical significance of domestic fluoroquinolones combinations with other antimicrobial agents
Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.
Ciprofloxacin in elderly patients with underlying chronic diseases.
In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Ciprofloxacin in neonatal Enterobacter cloacae septicaemia.
Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.
Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration.
Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys.
Enterococci in human periodontitis.
Continuous ambulatory peritoneal dialysis (CAPD) peritonitis: the effect of antibiotic on the adherence of coagulase-negative staphylococci to silicone rubber catheter material.
Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years.
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes.
Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients.
Ciprofloxacin and the inner ear--a morphological and round window membrane permeability study.
The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin.
An overview of the pharmacology of intravenously administered ciprofloxacin.
Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model.
Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models.
Single and multiple dose pharmacokinetics of ciprofloxacin in gynecological tissues.
Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies.
Effect of ciprofloxacin on phagocytosis.
The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant gram-negative bacteria.
Antibiotic resistance plasmids from Serratia marcescens and their elimination by DNA-gyrase inhibitors
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases anti-malarial activity.
Ciprofloxacin decreases the rate of ethanol elimination in humans.
Prolonged ciprofloxacin administration does not accelerate neutrophil recovery after autologous bone marrow transplantation.
Influence of renal failure on intestinal clearance of ciprofloxacin in rats.
Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study.
Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin.
The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.
In vitro study of the interaction between quinolones and polyvalent cations.
Ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: associated factors and resistance to other antibiotics.
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients.
Ciprofloxacin use under a reserved drug and stepdown promotion program.
The pharmacology of orally administered ciprofloxacin.
The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.
Tolerance of intravenously administered ciprofloxacin.
Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.
Biodegradable polylactic acid nanocapsules containing ciprofloxacin: preparation and characterization.
Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
Simultaneous determination of enrofloxacin and ciprofloxacin in animal biological fluids by high-performance liquid chromatography. Application in pharmacokinetic studies in pig and rabbit.
The efficacy of antibiotics enhanced by electrical currents against Pseudomonas aeruginosa biofilms.
Effects of taraxacum mongolicum on the bioavailability and disposition of ciprofloxacin in rats.
Simultaneous determination of grepafloxacin, ciprofloxacin, and theophylline in human plasma and urine by HPLC.
Distribution of ciprofloxacin in the isolated rat lung in the presence and absence of tissue oedema.
Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.
The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Influence of fluoroquinolones on the central action of ethanol.
Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms.
In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center.
Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.
Distribution of ciprofloxacin into the central nervous system in rats with acute renal or hepatic failure.
Determination of fluoroquinolone residues in animal tissues by liquid chromatography.
In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Antibacterial activity of liposome-encapsulated antibiotics against Pseudomonas aeruginosa attached to the matrix of human dermis.
Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.
Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan.
Chronic bone infections after surgery. Treatment with the new quinolones
Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group.
Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates.
Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: a 6-year study of isolates from patients in England and Wales.
Influence of Sanguisorba officinalis, a mineral-rich plant drug, on the pharmacokinetics of ciprofloxacin in the rat.
Effects of ethanol on intestinal absorption of drugs: in situ studies with ciprofloxacin analogs in acute and chronic alcohol-fed rats.
Is ciprofloxacin active against clinically important anaerobes?
Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli.
Epidemiology and treatment outcome of infection with antibiotic resistant strains of Neisseria gonorrhoeae in Scotland.
Alterations in macromolecular composition and cell wall integrity by ciprofloxacin in Mycobacterium smegmatis.
Glycosylation of fluoroquinolones through direct and oxygenated polymethylene linkages as a sugar-mediated active transport system for antimicrobials.
Aminoglycosides activate oxygen metabolites production in the cochlea of mature and developing rats.
Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Design of infection-resistant antibiotic-releasing polymers: I. Fabrication and formulation.
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Activity of 4-quinolones against Pseudomonas aeruginosa.
Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
Emerging ciprofloxacin-resistant Pseudomonas aeruginosa.
Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
Determination of fluoroquinolone residues in animal tissues using Escherichia coli as indicator organism.
Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin.
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
Adverse testicular effects of some quinolone members in rats.
Sub-MIC ciprofloxacin effect on fimbrial production by uropathogenic Escherichia coli strains.
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection.
Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal.
Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.
Frequency and susceptibility to antibiotics of Neisseria gonorrhoeae at Lome
Chondrotoxicity of ciprofloxacin in immature beagle dogs: immunohistochemistry, electron microscopy and drug plasma concentrations.
Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
Trend of antimicrobial resistance in Neisseria gonorrhoeae at New Delhi, India.
A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Penetration of ciprofloxacin and cefoperazone into human pancreas
Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital.
Ciprofloxacin intravenous dose variance.
Activity of ciprofloxacin against genital tract pathogens.
Tympanostomy tubes and otic suspensions: do they reach the middle ear space?
Validation of a reversed-phase LC method for quantitative analysis of intravenous admixtures of ciprofloxacin and metronidazole.
Effect of preoperative interventions on outcome following liver resection in a rat model of cirrhosis.
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa.
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates
Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing.
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.
Ciprofloxacin in acute exacerbations of chronic bronchitis.
Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Determination of plasma ciprofloxacin levels in children treated with 0.2% topical ciprofloxacin for tympanic perforation
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal.
Localized drug delivery using crosslinked gelatin gels containing liposomes: factors influencing liposome stability and drug release.
Ciprofloxacin for treatment of tularemia in children.
Effects of trovafloxacin on the IL-1-dependent activation of E-selectin in human endothelial cells in vitro.
An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms.
The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism.
A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial.
Pharmacokinetics of enrofloxacin administered intravenously and orally to foals.
Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis
Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin.
The effect of fluoroquinolones on the adhesive properties of different plasmidovars of Yersinia pseudotuberculosis
In vitro activities of amifloxacin and two of its metabolites.
Ciprofloxacin in children: is arthropathy a limitation?
Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines.
Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.
Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin.
Is prophylactic ciprofloxacin effective in delaying biliary stent blockage?
Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Ciprofloxacin levels in pleural fluid and serum during systemic administration after pneumonectomy
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): comparative pharmacokinetics and the role of therapeutic drug monitoring.
In vitro stability of amikacin and ciprofloxacin administered through a Y-shaped catheter connection with 2 total parenteral nutrition formulations with different pH
Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group
The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro.
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens
Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp.
In vivo studies on nasal preparations of ciprofloxacin hydrochloride.
Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron.
In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
Effects of liposome-encapsulated ciprofloxacin on phagocytosis, nitric oxide and intracellular killing of Staphylcoccus aureus by murine macrophages.
Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites.
Rx drugs
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.
Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. National Nosocomial Infections Surveillance (NNIS) System.
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.
Prostate needle biopsy infection after four or six dose ciprofloxacin.
Effects of continuous exposure to ciprofloxacin on the outer membrane of P. aeruginosa.
Changes in serum levels of quinolones in rats under the influence of experimental trauma.
Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998.
Ciprofloxacin affects pregnancy loss in CBA/JxDBA/2J mice possibly via elevation of interleukin-3 and granulocyte macrophage-colony stimulating factor production.
Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy?
Effects of tyrosine kinase inhibitors on cell death induced by sodium fluoride and pertussis toxin in the pancreatic beta-cell line, RINm5F.
Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.
Rx drugs
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.
Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.
Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan.
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Determination by fluorimetric titration of the ionization constants of ciprofloxacin in solution and in the presence of liposomes.
Effect of bifidobacteria and lactobacillus and antibiotics in combination with common gnotobiological isolation on the survival of mice with acute radiation sickness
The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from rat dorsal root ganglion neurones.
Transepithelial intestinal excretion of ciprofloxacin in humans.
Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Rx drugs
Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber.
An audit of the clinical features and use of antimicrobials in adult diarrhoea.
Antimicrobial resistance of Enterococci in Lebanon.
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.
Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
In vitro adsorption of ciprofloxacin on activated charcoal and Talc.
Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy.
In vitro activity of Ro 23-9424, a dual-acting cephalosporin-quinolone antimicrobial agent.
Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells.
Comparative in vitro activities of new quinolones against coryneform bacteria.
Biofilm culture of Pseudomonas aeruginosa expressing lux genes as a model to study susceptibility to antimicrobials.
Quantitative analysis of metronidazole in intravenous admixture with ciprofloxacin by first derivative spectrophotometry.
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria
Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry.
Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora.
Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
Cost and dosing issues.
Selective separation and simultaneous determination of trace levels of five types of fluorinated quinolone drugs by thin-layer chromatography/fluorescence densitometry.
Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.
Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B.
Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan.
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.
Susceptibility of corneal and conjunctival pathogens to ciprofloxacin.
The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans.
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions.
In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci.
Interactions between ciprofloxacin, Mg2+, Mn2+ and DNA by electrochemical method
Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
Influence of dose on the distribution kinetics of ciprofloxacin and ofloxacin in the isolated hindlimb of the rat.
Mycobacterium fortuitum wound infection following laparoscopy.
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule.
Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
Changes in Acholeplasma laidlawii plasma membrane functions during development of resistance to ciprofloxacin and tetracycline
Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Effects of new quinolones on transepithelial electrical potential difference of tracheal mucosa in vivo.
Antimicrobial susceptibility of Clostridium difficile by E test.
Quinolone pharmacokinetics and metabolism.
Rx drugs
Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose.
In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy.
Incidence, spectrum and antibiotic sensitivity pattern of bacterial infections among patients with acute pancreatitis.
In-vitro activity of fleroxacin.
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich.
Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Effect of ciprofloxacin in an in-vitro pharmacokinetic model against Pseudomonas aeruginosa isolated during cystic fibrosis lung infection.
Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid
Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods.
Development of infection resistant polyurethane biomaterials using textile dyeing technology.
Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones.
Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones.
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
Rx drugs
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
Multidrug resistance to antibacterial drugs of Salmonella enterica subsp. enterica strains isolated in Poland in the 1998-1999 period
Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli.
Effects of repeated rifabutin administration on the pharmacokinetics of intravenous and oral ciprofloxacin in mice.
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Differences between two new quinolones (gemifloxacin and trovafloxacin) and ciprofloxacin in their concentration-dependent killing of Streptococcus pneumoniae.
Grepafloxacin, a dimethyl derivative of ciprofloxacin, acts preferentially through gyrase in Streptococcus pneumoniae: role of the C-5 group in target specificity.
Active efflux of antibiotics as multiple-antibiotic-resistance mechanism in clinical strains of escherichia coli
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1.
Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells.
Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections
Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin
In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501
Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.
Increased expression of the multidrug efflux genes acrAB occurs during slow growth of Escherichia coli.
Rx drugs
In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.
Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice.
Rx drugs
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Rx drugs
Lack of interaction of fluoroquinolones with lipopolysaccharides.
Pharmacokinetics of ciprofloxacin in patients with liver cirrhosis.
Rx drugs
Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials.
Genetics of thermotolerance in ciprofloxacin resistant mutant of Rhizobium leguminosarum bv phaseoli.
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
In vitro and in vivo antibacterial activities of KB-5246, a new tetracyclic quinolone.
Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.
Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium.
In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone.
Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model.
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
In vivo evaluation of interaction between aqueous seed extract of Garcinia kola Heckel and ciprofloxacin hydrochloride.
The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay).
Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep.
Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip.
Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Bacterial strain-independent AUC/MIC and strain-specific dose-response relationships reflecting comparative fluoroquinolone anti-pseudomonal pharmacodynamics in an in vitro dynamic model.
Peptide dendrimers based on polyproline helices.
Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences
In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
Development of fluoroquinolone (ciprofloxacin) resistance in Mycoplasma hominis in the presence of Hela cells
High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
Determination of residues of enrofloxacin and its metabolite ciprofloxacin in chicken muscle by capillary electrophoresis using laser-induced fluorescence detection.
Determination off four fluoroquinolones in milk by liquid chromatography.
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
Ciprofloxacin increases hepatic and renal lipid hydroperoxides levels in mice.
Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland.
Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin.
Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad.
Rx drugs
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
gyrA and gyrB mutations are implicated in cross-resistance to Ciprofloxacin and moxifloxacin in Clostridium difficile.
Simultaneous assay of fluoroquinolones and theophylline in plasma by high-performance liquid chromatography.
The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
In vitro activity of PD 127,391, an enhanced-spectrum quinolone.
Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features.
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits.
Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.
Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae.
Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin
Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae.
Susceptibility to antibiotics and biochemical activity of strains of Acinetobacter sp. isolated from various sources
Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.
Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the treatment of intra-abdominal infections.
Phenotypic and genotypic characterization of food animal isolates of Salmonella with reduced sensitivity to ciprofloxacin.
Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry.
Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype.
Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E.
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
The fluoroquinolones.
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.
Effect of ciprofloxacin on adhesive properties of non-P mannose-resistant uropathogenic Escherichia coli isolates.
Interactions of the 4-quinolones with other antibacterials.
Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Epileptogenic effect of antibiotic drugs.
In vitro effects of ciprofloxacin and roxithromycin on apoptosis of jurkat T lymphocytes.
Empirical aminoglycosides for peritonitis do not affect residual renal function.
Experimental study on anti-duck hepatitis B viral effect of Phyllanthus urinaria of different areas and combined therapy with other drugs
In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin
Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.
DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli.
Activity of and resistance to moxifloxacin in Staphylococcus aureus.
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
Dosage adjustment of antiinfective therapy in patients with renal impairment.
Ciprofloxacin interaction with silicon-based and conventional hydrogel contact lenses.
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca
A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.
In vitro pharmacodynamic properties of a fluoroquinolone pharmaceutical derivative: hydrochloride of ciprofloxacin-aluminium complex.
Reliability of phototoxic tests of fluoroquinolones in vitro.
Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion.
In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials.
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.
Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India.
The influence of antimicrobial prophylaxis on the microbial and clinical findings in patients after autologous bone marrow transplantation.
Ciprofloxacin reduces the stimulation of prostaglandin E(2) output by interleukin-1beta in human tendon-derived cells.
Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro.
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin.
Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Rx drugs
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
Plasmid profiles and antimicrobial susceptibility of Campylobacter jejuni isolated from Israeli children with diarrhea.
An unusually high occurrence of Salmonella enterica serotype paratyphi A in patients with enteric fever.
In vitro activity of 9 antimicrobial agents against 177 strains of Haemophilus influenzae isolated from hospitalized patients.
Influence of copper(II) and magnesium(II) ions on the ciprofloxacin binding to DNA.
Molecular characterization of ciprofloxacin resistance of gonococcal strains in Spain.
Determination of ciprofloxacin in urine using terbium ion as fluorescent probe
Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis.
Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males corrected
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains.
In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci
Analysis of enrofloxacin and its metabolite ciprofloxacin in bovine and porcine muscle by high-performance liquid chromatography following cation exchange clean-up.
Penetration of ciprofloxacin into human peritoneal tissue following a single oral dose of 750 milligrams.
Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.
Ciprofloxacin and other antimicrobial drugs in the treatment of disseminated peritonitis
Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex.
Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
Evaluation of four newer antimicrobial agents in the Avantage susceptibility test system.
In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance.
Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-2-(4-fluorophenyl)-2-oxoethylciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.
In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis
A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis.
SOS response promotes horizontal dissemination of antibiotic resistance genes.
Effects of ciprofloxacin on foetal hepatocytes.
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Structural characterization of an unknown metabolite of ciprofloxacin
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.
Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.
Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median followup of 30 months.
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
Measurement of ciprofloxacin in human plasma, whole blood, and erythrocytes by high-performance liquid chromatography.
Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics.
Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
New techniques for assessing pathogenicity of quinolone-resistant bacteria.
Use of a non-radioactive DNA hybridization technique to study the effect of quinolone antibiotics on plasmid replication and curing.
Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery.
Penetration of ciprofloxacin into human pleural fluid.
Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy.
Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
An update on the efficacy of ciprofloxacin in animal models of infection.
Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function.
Activity of ciprofloxacin in the treatment of experimental intra-abdominal abscesses in mice.
Use of oral ciprofloxacin in community-acquired pneumonia.
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus
Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group.
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
Oral ciprofloxacin therapy for infections in cancer patients.
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.
Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice.
Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis
Efficacy of ciprofloxacin in stationary-phase bacteria in vivo.
Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model
Evaluation of the Cobas Bact automated system for susceptibility testing of Enterobacteriaceae, Pseudomonas aeruginosa, and Enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards.
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Mutational resistance to 4-quinolone antibacterial agents.
In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383.
The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol.
Penetration of ciprofloxacin in bronchial secretions after intravenous administration.
In vitro bacteriostatic and bactericidal effect of ciprofloxacin and others quinolone derivatives on Campylobacter jejuni
Aqueous humor penetration of ciprofloxacin in the human eye.
Ciprofloxacin concentrations in tonsils following single or multiple administrations.
Efficacy of ciprofloxacin in patients with cystic fibrosis.
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection.
Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.
In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea.
Production and induction of a novel cytotoxin (factor 2) by a human B-cell line.
The effect of ciprofloxacin on epinephrine and collagen-induced thrombocyte aggregation in vitro
The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease.
Ciprofloxacin concentrations in tonsils following a single intravenous infusion.
Penetration of ciprofloxacin into bone: a new bioabsorbable implant.
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.
A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative beta-lactam, aminoglycoside and fluoroquinolone.
Changes in phagocytosis of aerobic bacteria by neutrophils after exposure to subinhibitory concentrations of aztreonam and ciprofloxacin
Effects of ciprofloxacin and vancomycin on physicochemical surface properties of Staphylococcus epidermidis, Escherichia coli, Lactobacillus casei and Lactobacillus acidophilus.
Dissociated resistance among fluoroquinolones.
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition.
Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats.
Antimicrobial activities of ciprofloxacin against recently obtained clinical isolates
Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
The role of ciprofloxacin in endophthalmitis therapy.
Evidence that the antibiotic ciprofloxacin counteracts cyclosporine-dependent suppression of cytokine production.
The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms.
Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg.
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.
In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994. What was the impact of ciprofloxacin as first-line therapy for gonorrhea?
Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
Experimental Bacillus cereus post-traumatic endophthalmitis and treatment wit